During the CY 2026 OPPS/ASC proposed rule stage, we published a draft list of the NDCs that would be included in the survey, if finalized, so hospitals would have ample opportunity to review and prepare to report their acquisition costs for those NDCs
No DAC matches the body's natural GH pulse pattern
For this reason, some doctors may not recommend this type of treatment to help weight or fat loss
Retatrutide, with roughly 28% to 30% at higher doses in Phase 3, ahead of CagriSema (~22.7%) and survodutide (~19% in Phase 2)
At 180.90(c)(4), we proposed that, in certain situations, CMS would decline to make available to hospitals the opportunity to have a CMP amount reduced
A: Ideally, the solution should be at room temperature (approximately 20-25C) when you inject